Showing results (501-510 of 733) with videos related to

Sort By:
Pageof 74
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccineSjoerd H van der Burg, Anand G Menon, Anke Redeker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trialJ G H van Nes, C Seynaeve, E Maartense, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 TrialsLisette M Wiltink, Remi A Nout, Marta Fiocco, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 24, 2014
Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancerA Charehbili, M N Wasser, V T H B M Smit, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 1, 2014
High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selectionMariette Labots, Tineke E Buffart, Josien C Haan, et al.
Medicine|March 9, 2017
No association between metformin use and survival in patients with pancreatic cancer: An observational cohort studyMartine A Frouws, Babs G Sibinga Mulder, Esther Bastiaannet, et al.
World Journal of Gastroenterology|April 8, 2016
Near-infrared fluorescence sentinel lymph node detection in gastric cancer: A pilot studyQuirijn R J G Tummers, Leonora S F Boogerd, Wobbe O de Steur, et al.
Breast Cancer Research and Treatment|March 13, 2016
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysisCharla C Engels, Mandy Kiderlen, Esther Bastiaannet, et al.
Pageof 74